Silvant Capital Management LLC Invests $1.68 Million in Cigna Group $CI
Silvant Capital Management LLC has acquired a new stake in Cigna Group, purchasing 6,105 shares valued at approximately $1.68 million during the second quarter. This investment comes as Cigna reported strong quarterly earnings, beating estimates with $7.78 per share and a 6.7% revenue increase year-over-year. The company also announced a quarterly dividend of $1.56 per share, reinforcing its financial health and attracting institutional interest, with collective ownership now at 86.99%.
Tocqueville Asset Management L.P. Makes New $1.31 Million Investment in Cigna Group $CI
Tocqueville Asset Management L.P. has initiated a new position in Cigna Group (NYSE:CI), acquiring 4,741 shares valued at approximately $1.31 million during the second quarter. This move is part of broader institutional interest, with other firms also adjusting their holdings in the health services provider. Cigna Group's stock has seen varied analyst ratings, with a consensus of "Moderate Buy" and a target price of $339.45, alongside recent insider stock sales.
Vise Technologies Inc. Buys New Shares in Cigna Group $CI
Vise Technologies Inc. has acquired a new position in Cigna Group (NYSE:CI) by purchasing 18,091 shares valued at approximately $4.99 million during the second quarter. This move aligns with other institutional investors increasing their holdings, with institutions and hedge funds now owning 86.99% of the stock. Cigna reported strong quarterly earnings, beating analyst expectations, and reaffirmed its fiscal 2026 EPS guidance while declaring a quarterly dividend of $1.56.
B. Metzler seel. Sohn & Co. AG Takes Position in Cigna Group $CI
B. Metzler seel. Sohn & Co. AG recently acquired a new stake of 35,312 shares in Cigna Group (NYSE:CI), valued at approximately $9.74 million, during the second quarter. Other institutional investors also bought or sold shares, with 86.99% of the stock owned by institutional investors and hedge funds. The article also details recent insider stock sales, analyst ratings, and Cigna Group's financial performance, including its latest earnings report and dividend announcement.
Allworth Financial LP Buys Shares of 32,481 Cigna Group $CI
Allworth Financial LP has acquired 32,481 shares of Cigna Group (NYSE:CI) in the second quarter, valued at approximately $8.95 million. Other institutional investors have also adjusted their holdings in Cigna, with 86.99% of the stock owned by institutions. Cigna Group reported strong Q2 earnings, surpassing analyst expectations, and announced a quarterly dividend of $1.56 per share.
Cigna Group (NYSE:CI) Insider Nicole Jones Sells 2,677 Shares
Cigna Group insider Nicole Jones sold 2,677 shares of the company's stock for approximately $748,516 under a pre-arranged Rule 10b5-1 plan, reducing her ownership by 9.37%. This transaction was disclosed in a legal filing with the SEC. Despite the insider selling, Cigna's latest quarterly results beat earnings expectations, and analysts maintain a "Moderate Buy" consensus with an average price target of $339.45.
Cigna Group (NYSE: CI) exec logs phantom stock awards
Bryan Holgerson, an executive at Cigna Group (NYSE: CI), recently received additional phantom stock units under the Executive Deferred Compensation Plan. These units, which are economically equivalent to Cigna common stock but will be settled in cash, were acquired on three separate dates in July and August 2026. Holgerson also holds indirect ownership of 735.9274 CI common shares through The Cigna Group's 401(k) Plan.
CIBC (TSX:CM) Stock Looks Cheap On Fair Value But Richer On Earnings
Canadian Imperial Bank of Commerce (TSX:CM) stock has seen a significant 238.4% return over the past three years. Despite this, valuation models, particularly the Excess Returns estimate, suggest the stock is still about 28.4% undervalued, implying its recent gains haven't fully captured its intrinsic worth based on expected profitability. However, while it appears cheap on fair value, its P/E ratio of 15.5x is higher than the broader Banks industry average, indicating investors are paying more for its earnings.
Cigna Group (NYSE: CI) HR chief sells 2,677 shares under 10b5-1 plan
Cigna Group executive Nicole S. Jones, EVP, Chief Administrative Officer and Chief Human Resources Officer, sold 2,677 shares of CI common stock on August 18, 2026, at $279.61 per share. This transaction was conducted under a Rule 10b5-1 trading plan established on May 4, 2026. Following the sale, Ms. Jones directly holds 25,880 shares and indirectly holds 1,451.2364 shares through a 401(k) plan.
131,800 Shares in Healthcare Services Group, Inc. $HCSG Bought by Lisanti Capital Growth LLC
Lisanti Capital Growth LLC recently acquired a new stake of 131,800 shares in Healthcare Services Group, Inc. (NASDAQ:HCSG), valued at approximately $3.24 million. Other institutional investors also adjusted their positions in the company, which saw its stock rise by 4.5%. Healthcare Services Group reported strong Q2 earnings, beating analyst expectations, and has received a "Moderate Buy" rating from analysts with an average price target of $26.50.
CareCloud confirms massive data breach after 3.7M patients’ records stolen – What we know
CareCloud has confirmed a massive data breach that compromised the medical and personal records of over 3.7 million patients. The March cyberattack, which involved hackers accessing and removing data from CareCloud’s Amazon Web Services account, is now the fifth-largest US healthcare data theft of 2026. Stolen information includes names, addresses, Social Security numbers, medical records, government IDs, and financial details, leaving affected individuals vulnerable to identity theft and fraud.
Diversify Advisory Services LLC Invests $1.52 Million in Cigna Group $CI
Diversify Advisory Services LLC has invested $1.52 million in Cigna Group (NYSE:CI) by purchasing 5,230 shares in the second quarter. Cigna has received a "Moderate Buy" rating from analysts with an average price target of $339.45, reflecting positive sentiment. The company also reported strong quarterly earnings, beating expectations, and declared a quarterly dividend of $1.56.
134,188 Shares in Cigna Group $CI Bought by Danske Bank A S
Danske Bank A S acquired a new stake in Cigna Group (NYSE:CI) during the second quarter, purchasing 134,188 shares valued at approximately $36.99 million. This makes Danske Bank A S the owner of about 0.05% of Cigna Group. Several other institutional investors also adjusted their holdings in Cigna, while some insiders sold shares.
Here's Why Investors Should Stay Neutral on Cigna Stock for Now
Cigna (CI) demonstrates growth through strong segmental performance, improved operating efficiency, and shareholder-friendly actions, with its forward P/E lower than the industry average. Despite strong prospects and a Zacks Rank #3 (Hold) with a Value Score of A, the company faces risks such as escalating benefits and expenses, a deteriorating medical cost ratio, and significant long-term debt. Investors are advised to remain neutral due to these offsetting factors, while other medical stocks like BrightSpring Health Services, Globus Medical, and Centene Corporation are highlighted as strong buys.
CVS Health and Aetna Help Florida City Families Prepare for the School Year at Branches' Back to School Night
CVS Health and Aetna partnered with Branches Florida City to host a Back to School Night, providing over 250 students and their families with backpacks, school supplies, and hygiene kits. CVS Health also made a $100,000 donation to Branches to support its programs. The event aimed to prepare children for the new school year and foster community spirit with various family activities.
Danica Pension Livsforsikringsaktieselskab Purchases New Shares in Cigna Group $CI
Danica Pension Livsforsikringsaktieselskab has acquired a new position in Cigna Group, purchasing 27,610 shares valued at approximately $7.61 million. This comes as several other institutional investors have also adjusted their holdings in the health services provider. Wall Street analysts currently rate Cigna Group with a "Moderate Buy" and an average target price of $339.45.
94,763 Shares in Cigna Group $CI Bought by Bruni J V & Co. Co.
Bruni J V & Co. Co. has acquired 94,763 shares of Cigna Group (NYSE:CI), valued at over $26 billion, making it the 18th largest holding in their portfolio. This acquisition, along with other institutional investor activities, indicates strong institutional interest in Cigna, which currently holds a "Moderate Buy" consensus rating from analysts with a target price of $339.45. Cigna recently surpassed quarterly earnings expectations and declared a quarterly dividend of $1.56, reflecting a 2.2% annual yield.
Soon you can buy Medicare Advantage plans at Costco. What you need to know.
Costco Wholesale is expanding its offerings by partnering with nonprofit insurer SCAN Group to sell jointly branded Medicare Advantage and Medicare supplement plans. This move makes Costco the latest consumer brand to venture into offering health insurance options. The new plans will be available alongside Costco's existing wide range of products and services.
Cigna Group stock outperforms competitors on strong trading day
Cigna Group (CI) stock rose 1.15% to $278.50 on Tuesday, outperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average both declined. Despite the strong trading day, the company's shares remain 11.72% below their 52-week high.
Cigna Group (NYSE: CI) insider to sell 2,677 common shares
Cigna Group insider Nicole S. Jones has filed a Rule 144 notice, indicating a planned sale of 2,677 shares of common stock following a stock option exercise scheduled for August 18, 2025. This filing also reports that Jones previously sold 19,436 shares of Cigna common stock for over $5.3 million during the past three months. The transaction will be facilitated by Fidelity Brokerage Services LLC.
Dynatrace Prices $1.25 Billion Private Debt Offering
Dynatrace (NYSE:DT) has priced a private debt offering of $1.25 billion. This announcement follows an earlier plan to conduct such an offering. The company specializes in an AI-powered observability platform for digital businesses, focusing on optimizing cloud and IT operations, enhancing secure software delivery, and improving digital performance.
Pzena Investment Management LLC Sells 16,412 Shares of Cigna Group $CI
Pzena Investment Management LLC reduced its stake in Cigna Group (NYSE:CI) by 2.8% in Q2, selling 16,412 shares and retaining 562,036 shares valued at $154.9 million. Institutional investors and hedge funds collectively own 86.99% of the company. Cigna reported strong Q2 earnings, beating analyst expectations, and reaffirmed its fiscal 2026 EPS guidance, while also declaring a quarterly dividend of $1.56 per share.
Trust Co. of Vermont Makes New $4.23 Million Investment in Cigna Group $CI
Trust Co. of Vermont recently invested $4.23 million in Cigna Group (NYSE:CI) by acquiring 15,346 shares. Other institutional investors have also adjusted their holdings, with hedge funds and institutional investors collectively owning 86.99% of the company's stock. Analysts currently rate Cigna Group as a "Moderate Buy" with an average target price of $339.45.
Morgan Stanley Adjusts PT on Life Time Group to $53 From $39, Keeps Overweight Rating
Morgan Stanley has increased its price target for Life Time Group Holdings, Inc. (LTH) to $53 from $39, while maintaining an Overweight rating on the stock. This adjustment reflects a positive outlook on the company's future performance. The article also lists recent insider transactions and other analyst adjustments for Life Time Group.
Axe Compute Inc. And Duos Technologies Group, Inc. Enter Into Agreements For 55 MW Of New AI Data Center Capacity Across Multiple U.S. Locations
Axe Compute Inc. and Duos Technologies Group, Inc. have signed agreements for 55 MW of new AI data center capacity across various U.S. locations. Axe Compute will also make minority investments in the entities associated with these projects, aiming for a 49% equity stake, which will give it greater control over capacity, costs, and expansion. This strategic move aligns with Axe Compute's "Build model" and provides a non-dilutive financing method for Duos Technology to accelerate its data center launches.
Global Retirement Partners LLC Acquires Shares of 4,961 Cigna Group $CI
Global Retirement Partners LLC recently acquired 4,961 shares of Cigna Group (NYSE:CI) valued at approximately $1.37 million during the second quarter. Cigna reported strong quarterly earnings of $7.78 per share, surpassing estimates, with revenues rising 6.7% year-over-year to $70.04 billion, and maintained its fiscal 2026 earnings guidance. Despite a slight dip in share price on Tuesday, analysts maintain a "Moderate Buy" rating with an average price target of $339.45.
BlackRock Inc. Acquires 840,098 Shares of Cigna Group $CI
BlackRock Inc. increased its stake in Cigna Group (NYSE:CI) by 3.7% in the second quarter, acquiring an additional 840,098 shares, bringing its total holdings to 23.44 million shares, representing 8.87% of the company. Other institutional investors also adjusted their positions in Cigna. The health services provider reported strong quarterly earnings of $7.78 per share, exceeding estimates, and maintained its full-year earnings guidance, while analysts largely recommend a "Moderate Buy" rating with an average price target significantly above the current stock price.
Cigna Group stock underperforms Monday when compared to competitors
Shares of Cigna Group (CI) fell 2.56% on Monday, closing at $275.33, underperforming the broader market. This drop ended a three-day winning streak for the company, as both the S&P 500 Index and Dow Jones Industrial Average also saw declines.
Health systems test real-time prior auths through Epic
Four health systems—Ochsner Health, Froedtert ThedaCare, Denver Health, and Summit Health—are piloting Epic's new Coverage Requirements Discovery (CRD) API to streamline prior authorizations for major insurers. This API integrates prior authorization requirements directly into the EHR system at the point of scheduling or order placement, aiming to reduce administrative burden and comply with upcoming federal interoperability rules. The initiative seeks to make real-time prior authorizations possible, addressing a long-standing pain point for providers and improving patient care efficiency.
Starling Oncology Launches Starling Nexus Technology Platform To Optimize Oncology Provider Engagement And Accelerate High-Quality Care
Starling Oncology has launched Starling Nexus, a new technology platform designed to streamline oncology care by optimizing provider engagement and accelerating high-quality treatment. The platform aims to address challenges in NCCN compliance and the burdensome prior authorization process by integrating clinical decision support with utilization management into a single digital workflow. Starling Nexus will also serve as a hub for integrating ancillary services like pharmacy and clinical trials, supporting physicians, health plans, and patients in managing complex cancer care.
DataMEDS AI, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
DataMEDS AI, Inc. announced its earnings results for the second quarter and six months ending June 30, 2026. For the second quarter, the company reported a significant decrease in sales to $1.78 million and a net loss of $18.36 million. The six-month period also saw a drop in sales to $3.34 million, though the net loss improved to $26.11 million compared to the previous year.
OneDigital Investment Advisors LLC Increases Position in Cigna Group $CI
OneDigital Investment Advisors LLC significantly increased its stake in Cigna Group by 47.3% in the second quarter. This occurred as Cigna reported strong quarterly earnings, beating EPS estimates, and maintained its fiscal 2026 EPS guidance. The company also announced a quarterly dividend, and analysts largely maintain a "Moderate Buy" rating for the stock.
GSA Capital Partners LLP Buys 5,056 Shares of Cigna Group $CI
GSA Capital Partners LLP increased its stake in Cigna Group (NYSE:CI) by 311.3% in the second quarter, purchasing an additional 5,056 shares to own a total of 6,680 shares valued at $1.84 million. Other hedge funds and institutional investors also adjusted their positions in Cigna Group. The article details Cigna's financial performance, dividend announcement, recent insider trading activity, and analyst ratings, with the stock currently holding a "Moderate Buy" consensus.
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook
Progyny (NASDAQ: PGNY) anticipates a rebound in fertility-treatment utilization after a summer slowdown, with September appointment trends returning to earlier levels. The company's full-year outlook is de-risked by early renewal commitments and strong new-client acquisition, targeting at least 1 million new covered lives. Progyny also sees expanding growth opportunities, including replacement business, health-plan partnerships, and new offerings like Progyny Select, which has increased its estimated addressable market to 155 million lives.
Focus Partners Advisor Solutions LLC Lowers Stock Holdings in Cigna Group $CI
Focus Partners Advisor Solutions LLC significantly reduced its stake in Cigna Group (NYSE:CI) by 52.7% in the second quarter, selling 4,192 shares and retaining 3,764 shares valued at $1,038,000. Despite this reduction by one firm, other institutional investors have either increased their holdings or initiated new positions in Cigna Group. The company recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend of $1.56 per share.
Q2 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks
The Q2 earnings season for health insurance providers saw mixed results, with Cigna (NYSE:CI) exceeding revenue and EPS estimates but seeing a stock decline. CVS Health (NYSE:CVS) also beat expectations across the board but experienced a similar stock drop. Progyny (NASDAQ:PGNY) delivered the weakest guidance, while Clover Health (NASDAQ:CLOV) reported strong growth and positive stock performance.
Q2 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks
The article reviews the Q2 2026 earnings season for health insurance providers, highlighting Cigna's performance along with CVS Health as a top performer and Progyny as the weakest. It discusses sector-wide trends including revenue beats, declining share prices post-earnings, and the industry's sensitivity to regulatory changes, economic conditions, and the potential impact of AI.
Is agilon health (AGL) Overvalued On Raised 2026 Guidance And Q2 Beat?
Agilon health (AGL) experienced a significant stock jump after reporting a Q2 beat and raised full-year guidance for 2026, including higher revenue and EBITDA. Despite this positive news and a strong year-to-date return, the company's stock is considered 24% overvalued based on a fair value of $78.14, compared to its closing price of $96.90. However, an alternative view suggests it could be undervalued when looking at its P/S ratio relative to peers and the industry, indicating that the market might be pricing in execution risk rather than strong upside potential.
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook
Progyny's CEO, Pete Anevski, announced that the company anticipates a rebound in member engagement and utilization after a more significant summer slowdown. Early renewal commitments and new client acquisitions have bolstered management's confidence in the company's financial outlook for the remainder of the year. Progyny also reported stronger early new-business commitments and an expansion of its client base across numerous industries, de-risking its renewal rates for the upcoming year.
Russell Investments Group Ltd. Purchases 19,937 Shares of Cigna Group $CI
Russell Investments Group Ltd. increased its stake in Cigna Group (NYSE:CI) by 2.4%, acquiring an additional 19,937 shares, bringing its total to 844,481 shares valued at approximately $233 million. Other institutional investors also adjusted their holdings. Cigna reported strong Q2 earnings, exceeding estimates with $7.78 per share and revenue of $70.04 billion, and announced a quarterly dividend of $1.56.
Mitsubishi UFJ Trust & Banking Corp Raises Position in Cigna Group $CI
Mitsubishi UFJ Trust & Banking Corp increased its stake in Cigna Group by 8.8% in the second quarter, bringing its total holdings to 206,656 shares valued at $57.0 million. Institutional investors now own 86.99% of Cigna's outstanding stock. The company recently reported exceeding quarterly earnings expectations with adjusted EPS of $7.78 and revenue of $70.04 billion, and also declared a quarterly dividend of $1.56.
KBC Group NV Buys 22,978 Shares of Cigna Group $CI
KBC Group NV increased its stake in Cigna Group (NYSE:CI) by 6.4% in the second quarter, acquiring an additional 22,978 shares, bringing their total ownership to 380,034 shares valued at over $104 million. Other institutional investors also adjusted their positions in Cigna, with hedge funds and institutional investors collectively owning 86.99% of the company's stock. Cigna reported strong Q2 earnings, beating consensus estimates, and announced a quarterly dividend of $1.56 per share.
LFG Wealth Partners LLC Makes New $1.70 Million Investment in Cigna Group $CI
LFG Wealth Partners LLC has made a new $1.70 million investment in Cigna Group (NYSE:CI), acquiring 6,150 shares during the second quarter. Cigna exceeded quarterly earnings expectations with $7.78 EPS and $70.04 billion in revenue, representing a 6.7% year-over-year increase. The company also declared a $1.56 quarterly dividend, and analysts maintain a "Moderate Buy" consensus with an average price target of $339.45.
HighTower Advisors LLC Buys 283,897 Shares of Cigna Group $CI
HighTower Advisors LLC significantly increased its stake in Cigna Group (NYSE:CI) by 402.7% in the second quarter, purchasing an additional 283,897 shares. This brings their total holdings to 354,398 shares, valued at approximately $97.7 million. Other hedge funds also adjusted their positions in Cigna, which recently reported earnings exceeding analyst expectations and declared a quarterly dividend of $1.56.
Cigna Group $CI Stock Position Trimmed by Fifth Third Bancorp
Fifth Third Bancorp reduced its stake in Cigna Group (NYSE:CI) by 5.5% in Q2, selling 4,197 shares but still holding 72,463 shares valued at approximately $20 million. Despite this trim, institutional investors collectively own 86.99% of Cigna's stock. The health services provider recently beat Q2 earnings estimates with $7.78 per share and saw revenue rise 6.7% year-over-year to $70.04 billion, maintaining its fiscal 2026 earnings guidance.
Pyrophyte Acquisition Corp. II Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
Pyrophyte Acquisition Corp. II has announced its earnings results for the second quarter and six months ending June 30, 2026. For the second quarter, the company reported a net income of USD 1.5 million. The net income for the full six-month period was USD 2.96 million.
GSR V Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
GSR V Acquisition Corp. announced its earnings results for the second quarter and six months ended June 30, 2026. The company reported a net income of USD 0.786553 million for the second quarter and USD 0.729868 million for the six-month period. GSR V Acquisition Corp. is a blank check company focused on mergers and acquisitions.
Qsemble Capital Management LP Makes New $2.08 Million Investment in Cigna Group $CI
Qsemble Capital Management LP has made a new $2.08 million investment in Cigna Group, purchasing 7,559 shares during the second quarter. Cigna reported strong quarterly earnings, beating analyst estimates with an EPS of $7.78 and a 6.7% increase in revenue year-over-year. The company also declared a quarterly dividend of $1.56, and analysts maintain a "Moderate Buy" rating with an average price target significantly above its current trading price.
Massachusetts Financial Services Co. MA Cuts Stock Position in Cigna Group $CI
Massachusetts Financial Services Co. MA significantly reduced its stake in Cigna Group (NYSE:CI) by 9.9% in the second quarter, selling 1.15 million shares but still holding a substantial position valued at $2.90 billion. Despite this reduction, Cigna maintains a "Moderate Buy" consensus rating from analysts with an average price target of $339.45, although some analysts have downgraded their ratings. The company recently surpassed earnings expectations with $7.78 EPS and announced a quarterly dividend of $1.56 per share.
Fox Run Management L.L.C. Trims Stock Position in Cigna Group $CI
Fox Run Management L.L.C. significantly reduced its stake in Cigna Group (NYSE:CI) by 81.3% in the second quarter, selling 3,975 shares and retaining 913 shares valued at approximately $252,000. Despite this reduction, Cigna maintains a "Moderate Buy" consensus rating from analysts with an average price target of $339.45. The company recently reported strong quarterly earnings, surpassing estimates with adjusted EPS of $7.78 and a 6.7% revenue increase year-over-year.
